Literature DB >> 9401658

Cranioplasty with autogenous autoclaved calvarial bone flap in the cases of tumoural invasion.

V Vanaclocha1, N Sáiz-Sapena, C García-Casasola, E De Alava.   

Abstract

When a bone flap is raised in the course of a craniotomy, the ideal is to replace it at the end of the procedure. When it is invaded by tumoural cells, it cannot be replaced due to the risk of tumoural recurrence. In these cases we have autoclaved the bone flap to be able to replace it with no fear of tumoural recurrence. Between October 1989 and October 1995 sixty-two patients required autoclaving of the bone flap in the course of a craniotomy due to tumoural invasion (thirty-five meningiomas, sixteen bone tumours, five metastases, and eight scalp tumours). The infiltrated bone flaps were removed, cleaned, autoclaved for 20 minutes at 134 degrees C and 1 kg/cm2 and re-implanted. Patients were followed-up for 10 to 58 months (average 41 months). At every follow-up visit skull x-ray studies, clinical examination, and photographs were done. When needed a CT scan was performed to assess the thickness of the bone flap. On follow-up roentgenograms partial resorption was observed in twelve cases (19.3%). CT scan studies showed loss of thickness in another thirty-five cases (56.4%). Meanwhile the external aspect remained unchanged. In six cases (3.2%) biopsies of the bone flaps were taken at a second surgical procedure. They showed newly formed bone partly re-populated by osteocytes but retaining areas of sequestered bone. We conclude that autoclaved bone, if replaced with direct contact with living bone, it is gradually repopulated with osteocytes. Cranial vault autoclaved autologous bone flap is a good alternative when the original bone flap is invaded but not destroyed by tumoural cells.

Entities:  

Mesh:

Year:  1997        PMID: 9401658     DOI: 10.1007/bf01411307

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  Intraoperative template-molded bone flap reconstruction for patient-specific cranioplasty.

Authors:  Serge Marbacher; Lukas Andereggen; Salome Erhardt; Ali-Reza Fathi; Javier Fandino; Andreas Raabe; Jürgen Beck
Journal:  Neurosurg Rev       Date:  2012-03-06       Impact factor: 3.042

2.  Cranioplasty using polymethyl methacrylate implant constructed from an alginate impression and wax elimination technique.

Authors:  Ae Abdulai; Mi Iddrissu; Tk Dakurah
Journal:  Ghana Med J       Date:  2006-03

3.  A giant, complex fronto-ethmoidal ivory osteoma: Surgical technique in a resource-limited practice.

Authors:  Amos Olufemi Adeleye
Journal:  Surg Neurol Int       Date:  2010-12-31

4.  Resorption of Autogenous Bone Graft in Cranioplasty: Resorption and Reintegration Failure.

Authors:  Si Hoon Lee; Chan Jong Yoo; Uhn Lee; Cheol Wan Park; Sang Gu Lee; Woo Kyung Kim
Journal:  Korean J Neurotrauma       Date:  2014-04-30

5.  Meningioma infiltrating into porous polymethylmethacrylate cranioplasty-report of a unique case.

Authors:  Karl-Michael Schebesch; Martin Proescholdt; Nils Ole Schmidt; Julius Höhne
Journal:  J Surg Case Rep       Date:  2020-06-19

6.  Bone Flap Changes after Cranioplasty Using Frozen Autologous Bone Flaps: A Three-Dimensional Volumetric Reconstruction Study.

Authors:  Jung Hwan Lee; Chung Kee Chough; Hyuk Jin Choi; Jun Kyeung Ko; Won Ho Cho; Seung Heon Cha; Chang Hwa Choi; Young Ha Kim
Journal:  Yonsei Med J       Date:  2019-11       Impact factor: 2.759

7.  Intraoperative Extracorporeal Irradiation for the Treatment of the Meningioma-Infiltrated Calvarium.

Authors:  Edward E Kerr; Ruben Fragoso; Rudolph J Schrot; Kiarash Shahlaie
Journal:  J Neurol Surg Rep       Date:  2015-06-26

8.  Functional investigation of bone implant viability using radiotracers in a new model of osteonecrosis.

Authors:  Luis Schiper; Bluma Linkowski Faintuch; Roberto José da Silva Badaró; Erica Aparecida de Oliveira; Victor E Arana Chavez; Elisangela Chinen; Joel Faintuch
Journal:  Clinics (Sao Paulo)       Date:  2016-10-01       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.